- Home
- CNTA vs LEU Comparison
CNTA vs LEU Comparison
Compare CNTA & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | LEU |
|---|---|---|
| Founded | 2020 | 1998 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.2B |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CNTA | LEU |
|---|---|---|
| Price | $25.11 | $205.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | $38.50 | ★ $243.00 |
| AVG Volume (30 Days) | ★ 1.5M | 1.4M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.90 |
| Revenue | N/A | ★ $193,000,000.00 |
| Revenue This Year | N/A | $4.90 |
| Revenue Next Year | N/A | $5.67 |
| P/E Ratio | ★ N/A | $52.99 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.60 | $49.77 |
| 52 Week High | $30.58 | $464.00 |
Technical Indicators
Market Signals| Indicator | CNTA | LEU |
|---|---|---|
| Relative Strength Index (RSI) | 56.34 | 38.06 |
| Support Level | $22.50 | $183.45 |
| Resistance Level | $25.80 | $276.89 |
| Average True Range (ATR) | 1.29 | 26.50 |
| MACD | 0.10 | -9.21 |
| Stochastic Oscillator | 63.34 | 14.15 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.